















Aging of biological systems ultimately leads to death of 
the individual. In humans, organ failure as the result of 
functional impairments after stroke, cardio-vascular 
disease, tumor development, neurodegeneration and 
other diseases are certainly crucial in bringing life to an 
end. But what happens in individuals with no obvious 
disease or disorders? 
 
In simple microorganisms like the single cellular fungus 
Saccharomyces  cerevisiae  (yeast)  very  basic  cellular 
processes, resembling mammalian programmed cell 
death (PCD) as they are important for development and 
protection against cancer, lead to death of the 
individuum [1,2]. In the last several years, PCD was 
also demonstrated to occur in multicellular fungi [2]. In 
the filamentous fungus Podospora anserina, a well 
established experimentally tractable short-lived aging 
model with a small genome, a role of PCD was recently 
demonstrated to be involved in aging and lifespan 
control [3-5]. Although differing in complexity, the 
molecular pathways controlling PCD in the different 
groups of organisms are conserved [6,7]. In a recent 
study we addressed the role of PaCYPD (cyclophilin D) 
of  P. anserina [8], a mitochondrial matrix protein 
previously found to increase in abundance in 
mitochondria during aging [9]. Cyclophilin D is a 
peptidyl prolyl-cis,trans-isomerase located in the 
mitochondrial matrix that is known to be involved in 
mitochondrial permeability pore transition (mPTP) [10], 
a process leading to opening of a membrane pore and to 
entrance of low molecular weight solutes into the 
mitochondrial matrix. The process leads to swelling of 
mitochondria, rupture of the outer membrane and the 
release of apoptogens (e.g., cytochrome c) from the 
intermembrane space and the subsequent induction of 
PCD. We now show that over-expression of PaCypD 
results in accelerating organismal aging. Chronological 

















aging’ phenotype with pronounced mitochondrial 
dysfunction, markers of senescence and apoptosis, and 
reduced stress tolerance. Treatment with the CYPD 
inhibitor cyclosporin A leads to correction of mito-
chondrial function and lifespan to that of the wild-type. 
 
It should be emphasized here that the induction of PCD 
as a final execution program in the life cycle of the 
fungus appears to result from complex aging processes. 
In  P. anserina, a number of different pathways 
including those leading to the generation and 
scavenging of reactive oxygen species [11-14], protein 
quality control [15], mitochondrial dynamics [16], and 
others [3,4] are known to be part of the complex 
network governing aging. 
 
It is now the challenge to identify other components of 
mitochondrial pore formation, characterize the pore 
biochemically, and to elucidate the detailed role of PCD 
in aging also in mammalian systems. Interestingly, an 
age-related increase of CYPD, as in P. anserina, was 
recently reported in rat gastrocnemius muscle and in 
brain tissue of mice and humans [17,18]. It is thus likely 
that the induction of PCD, at least in particular tissues 
and organs, also in human aging plays a more important 
role than it is currently anticipated. If so, it will be of 
special interest to investigate the potential of 
components like CSA, a cyclic peptide approved for 
human therapy in transplantation medicine or for 
treatment of Ullrich congenital muscular dystrophy, in 
being effective in postponing basic aging processes and 
using this knowledge to develop efficient strategies to 
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